Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anaphylaxis | 21 | 2021 | 746 | 3.880 |
Why?
|
| Food Hypersensitivity | 17 | 2021 | 622 | 2.910 |
Why?
|
| Epinephrine | 12 | 2021 | 793 | 2.250 |
Why?
|
| Insect Bites and Stings | 3 | 2013 | 67 | 0.910 |
Why?
|
| Hypersensitivity, Immediate | 2 | 2010 | 334 | 0.590 |
Why?
|
| Emergency Service, Hospital | 17 | 2021 | 7645 | 0.510 |
Why?
|
| Sunlight | 2 | 2015 | 325 | 0.480 |
Why?
|
| Allergens | 6 | 2021 | 1314 | 0.460 |
Why?
|
| Emergency Treatment | 2 | 2014 | 517 | 0.450 |
Why?
|
| Hospitalization | 10 | 2021 | 10232 | 0.440 |
Why?
|
| Ultraviolet Rays | 3 | 2015 | 1059 | 0.400 |
Why?
|
| Vitamin D | 3 | 2015 | 3211 | 0.350 |
Why?
|
| Patient Admission | 1 | 2017 | 1380 | 0.350 |
Why?
|
| Food | 2 | 2012 | 769 | 0.340 |
Why?
|
| Bronchodilator Agents | 3 | 2014 | 502 | 0.280 |
Why?
|
| Inpatients | 1 | 2017 | 2495 | 0.260 |
Why?
|
| Polymorphism, Genetic | 1 | 2015 | 4328 | 0.250 |
Why?
|
| Child, Preschool | 16 | 2021 | 40955 | 0.240 |
Why?
|
| Patient Education as Topic | 2 | 2013 | 2275 | 0.230 |
Why?
|
| Injections, Intramuscular | 2 | 2021 | 548 | 0.210 |
Why?
|
| Infant | 12 | 2021 | 35070 | 0.200 |
Why?
|
| Child | 16 | 2020 | 77478 | 0.180 |
Why?
|
| Self Administration | 3 | 2021 | 386 | 0.180 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2021 | 347 | 0.160 |
Why?
|
| Immunoglobulin E | 2 | 2021 | 1460 | 0.160 |
Why?
|
| Adolescent | 14 | 2021 | 85649 | 0.150 |
Why?
|
| Nitric Oxide Synthase | 1 | 2000 | 916 | 0.150 |
Why?
|
| Injections | 1 | 2020 | 840 | 0.150 |
Why?
|
| International Classification of Diseases | 3 | 2021 | 865 | 0.140 |
Why?
|
| Rhode Island | 1 | 2017 | 347 | 0.140 |
Why?
|
| Drug Hypersensitivity | 2 | 2015 | 883 | 0.130 |
Why?
|
| Calcium-Binding Proteins | 1 | 2000 | 1081 | 0.130 |
Why?
|
| NF-kappa B | 2 | 2003 | 2500 | 0.130 |
Why?
|
| Emergency Medical Services | 4 | 2021 | 1914 | 0.120 |
Why?
|
| Seasons | 2 | 2010 | 1492 | 0.120 |
Why?
|
| Trans-Activators | 2 | 2003 | 2924 | 0.120 |
Why?
|
| Eating | 1 | 2021 | 1535 | 0.120 |
Why?
|
| Length of Stay | 3 | 2017 | 6294 | 0.120 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2015 | 876 | 0.120 |
Why?
|
| Hypersensitivity | 2 | 2021 | 1093 | 0.110 |
Why?
|
| Humans | 36 | 2021 | 742088 | 0.110 |
Why?
|
| Eczema | 1 | 2015 | 229 | 0.110 |
Why?
|
| Mast Cells | 1 | 2020 | 1544 | 0.110 |
Why?
|
| Male | 21 | 2021 | 349538 | 0.110 |
Why?
|
| Allergy and Immunology | 1 | 2013 | 169 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2003 | 4553 | 0.100 |
Why?
|
| Medical Records | 3 | 2015 | 1413 | 0.100 |
Why?
|
| Female | 21 | 2021 | 379592 | 0.100 |
Why?
|
| Bee Venoms | 1 | 2010 | 14 | 0.100 |
Why?
|
| Bees | 1 | 2010 | 43 | 0.090 |
Why?
|
| Obesity | 1 | 2012 | 12705 | 0.090 |
Why?
|
| DNA-Binding Proteins | 3 | 2003 | 9639 | 0.090 |
Why?
|
| Clinical Protocols | 2 | 2012 | 1459 | 0.090 |
Why?
|
| United States | 10 | 2021 | 69693 | 0.080 |
Why?
|
| Urticaria | 1 | 2010 | 150 | 0.080 |
Why?
|
| Angioedema | 1 | 2010 | 187 | 0.080 |
Why?
|
| Skin Tests | 1 | 2010 | 612 | 0.080 |
Why?
|
| Infant, Newborn | 4 | 2021 | 25575 | 0.080 |
Why?
|
| Delphi Technique | 2 | 2021 | 778 | 0.080 |
Why?
|
| Consensus | 3 | 2021 | 2935 | 0.080 |
Why?
|
| Transcription Factors | 3 | 2003 | 12164 | 0.070 |
Why?
|
| Urban Population | 1 | 2015 | 2018 | 0.070 |
Why?
|
| Age Factors | 4 | 2017 | 18355 | 0.070 |
Why?
|
| Parturition | 1 | 2010 | 436 | 0.070 |
Why?
|
| Early Diagnosis | 1 | 2010 | 1184 | 0.070 |
Why?
|
| Sex Distribution | 1 | 2010 | 2295 | 0.060 |
Why?
|
| Adult | 12 | 2020 | 213712 | 0.060 |
Why?
|
| Retrospective Studies | 6 | 2021 | 77098 | 0.060 |
Why?
|
| Odds Ratio | 2 | 2014 | 9846 | 0.060 |
Why?
|
| Confidence Intervals | 1 | 2010 | 2970 | 0.060 |
Why?
|
| Age Distribution | 1 | 2010 | 2900 | 0.060 |
Why?
|
| Cost of Illness | 1 | 2014 | 1852 | 0.060 |
Why?
|
| Treatment Outcome | 5 | 2021 | 62966 | 0.060 |
Why?
|
| Drug Prescriptions | 1 | 2013 | 1636 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-ets | 2 | 2003 | 318 | 0.060 |
Why?
|
| Diet | 1 | 2021 | 7923 | 0.060 |
Why?
|
| Comorbidity | 2 | 2015 | 10372 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 13921 | 0.050 |
Why?
|
| Risk Factors | 6 | 2015 | 72145 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 4929 | 0.050 |
Why?
|
| Risk | 1 | 2014 | 9679 | 0.050 |
Why?
|
| Egg Hypersensitivity | 1 | 2021 | 44 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 7770 | 0.050 |
Why?
|
| Prevalence | 2 | 2015 | 15194 | 0.050 |
Why?
|
| Health Care Costs | 1 | 2014 | 3203 | 0.050 |
Why?
|
| Synaptotagmins | 1 | 2000 | 58 | 0.050 |
Why?
|
| Synaptotagmin I | 1 | 2000 | 36 | 0.050 |
Why?
|
| Synovial Membrane | 1 | 2003 | 506 | 0.050 |
Why?
|
| Eggs | 1 | 2021 | 184 | 0.040 |
Why?
|
| Middle Aged | 9 | 2015 | 213127 | 0.040 |
Why?
|
| Interleukin-1 | 1 | 2003 | 1262 | 0.040 |
Why?
|
| Peanut Hypersensitivity | 1 | 2021 | 163 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2000 | 534 | 0.040 |
Why?
|
| Young Adult | 6 | 2015 | 56350 | 0.040 |
Why?
|
| Critical Illness | 1 | 2010 | 2665 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 7153 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 2 | 2013 | 7276 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2010 | 8297 | 0.040 |
Why?
|
| Asthma | 1 | 2015 | 5955 | 0.040 |
Why?
|
| Time Factors | 2 | 2014 | 40054 | 0.030 |
Why?
|
| Aged | 6 | 2013 | 162944 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2020 | 950 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2000 | 1782 | 0.030 |
Why?
|
| Quality of Life | 1 | 2015 | 12730 | 0.030 |
Why?
|
| Adrenergic Agonists | 1 | 2013 | 58 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2000 | 3847 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2001 | 1659 | 0.030 |
Why?
|
| Terminology as Topic | 1 | 2020 | 1548 | 0.030 |
Why?
|
| Research | 1 | 2021 | 1999 | 0.030 |
Why?
|
| Incidence | 1 | 2010 | 20928 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 2001 | 5867 | 0.030 |
Why?
|
| Vascular Diseases | 1 | 2000 | 1155 | 0.030 |
Why?
|
| Binding Sites | 1 | 2000 | 6115 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2000 | 1889 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 4414 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2010 | 57683 | 0.020 |
Why?
|
| Shellfish | 1 | 2010 | 38 | 0.020 |
Why?
|
| Animals | 3 | 2013 | 168561 | 0.020 |
Why?
|
| Blotting, Northern | 2 | 2003 | 1581 | 0.020 |
Why?
|
| Acute Disease | 1 | 2021 | 7141 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 15530 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2000 | 3769 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2001 | 3617 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2010 | 23320 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 39004 | 0.020 |
Why?
|
| Recurrence | 1 | 2020 | 8333 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2003 | 3695 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2000 | 4465 | 0.020 |
Why?
|
| Boston | 2 | 2010 | 9305 | 0.020 |
Why?
|
| Logistic Models | 2 | 2013 | 13403 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2010 | 40450 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 3510 | 0.020 |
Why?
|
| Cytokines | 1 | 2000 | 7317 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2000 | 19223 | 0.020 |
Why?
|
| Disease Progression | 1 | 2020 | 13256 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2013 | 2266 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 2003 | 427 | 0.010 |
Why?
|
| Receptors, TIE | 1 | 2001 | 10 | 0.010 |
Why?
|
| Receptor, TIE-1 | 1 | 2001 | 12 | 0.010 |
Why?
|
| Allantois | 1 | 2001 | 33 | 0.010 |
Why?
|
| Chorion | 1 | 2001 | 117 | 0.010 |
Why?
|
| Inflammation | 1 | 2000 | 10578 | 0.010 |
Why?
|
| Patient Discharge | 1 | 2013 | 3300 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2013 | 3527 | 0.010 |
Why?
|
| Receptor, TIE-2 | 1 | 2001 | 178 | 0.010 |
Why?
|
| Vitamin D Deficiency | 1 | 2010 | 1331 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2003 | 1799 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 12242 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2014 | 7716 | 0.010 |
Why?
|
| Chick Embryo | 1 | 2001 | 981 | 0.010 |
Why?
|
| Chickens | 1 | 2001 | 865 | 0.010 |
Why?
|
| DNA Primers | 1 | 2003 | 2892 | 0.010 |
Why?
|
| Chondrocytes | 1 | 2003 | 803 | 0.010 |
Why?
|
| Cell Line | 2 | 2003 | 15994 | 0.010 |
Why?
|
| Osteoblasts | 1 | 2003 | 1163 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2001 | 794 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2001 | 1950 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2001 | 2837 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2001 | 2257 | 0.010 |
Why?
|
| Mutation | 1 | 2000 | 29717 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2001 | 2003 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4751 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2003 | 2211 | 0.010 |
Why?
|
| Osteoarthritis | 1 | 2003 | 1034 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2001 | 4322 | 0.010 |
Why?
|
| Blood Vessels | 1 | 2001 | 1124 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2003 | 4143 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2001 | 2867 | 0.010 |
Why?
|
| Macrophages | 1 | 2003 | 5655 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 2003 | 13029 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 2001 | 18112 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 11363 | 0.000 |
Why?
|
| Nuclear Proteins | 1 | 2001 | 5851 | 0.000 |
Why?
|
| Mice | 1 | 2001 | 81045 | 0.000 |
Why?
|
Concepts
(174)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(17)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_